Follow on Google News News By Tag * Depressive * Disorder * Therapeutics * Pipeline * Mdd * Cns * Clinical * Globaldata * Glaxosmithkline * Astrazeneca * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | New Report: Major Depressive Disorder (MDD) - Pipeline Assessment and Market Forecasts to 2017New Pharmaceuticals market report from GlobalData: "Major Depressive Disorder (MDD) - Pipeline Assessment and Market Forecasts to 2017"
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. GlobalData estimates the global MDD therapeutics market to be valued at $11.02bn in 2009. The market is estimated to decline by 3% to $9.0bn in 2017, which is attributed to patent expiry of Lexapro and Cymbalta in 2012 and 2013. However, the MDD market is anticipated to stabilize with the expected approval of Vilazodone and TC-5214 and the increasing public awareness. Scope The scope of the report includes: * Annualized global Hepatitis B therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. * Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan. * Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include selective serotonin reuptake inhibitor, serotonin and nenorepinephrine reuptake inhibitor, cortiocotropin releasing factor antagonist and AMPA receptor modulator. * Analysis of the current and future market competition in the global MDD therapeutics market. The key future market players covered are GlaxoSmithkline, AstraZeneca, Forest Laboratories, Merck & Co., Eli Lilly, Weyth (Pfizer) and Lundbeck. * Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. * Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the MDD therapeutics market. Reasons to buy The report will enhance your decision making capability. It will allow you to: * Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines. * Develop business strategies by understanding the trends shaping and driving the global MDD therapeutics market. * Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to affect the global MDD therapeutics market in the future. * Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. * Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. * Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships. * What's the next big thing in the global Hepatitis B therapeutics market landscape? Identify, understand and capitalize. For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: 1 Table of contents 3 1.1 List of Tables 5 1.2 List of Figures 5 2 Major Depressive Disorder Market: Introduction 6 2.1 GlobalData Pipeline Report Guidance 6 3 Major Depressive Disorder Market: Market Characterization 7 3.1 Overview 7 3.2 Depressive Disorder Market Size 7 3.3 Depression Market Forecast and CAGR 8 3.4 Drivers and Barriers for the Major Depressive Disorder Market 10 3.4.1 Drivers for the Major Depressive Disorder Market 10 3.4.2 Barriers for the Major Depressive Disorder Market 10 3.5 Opportunity and Unmet Need 11 3.6 Key Takeaway 12 4 Major Depressive Disorder Market: Competitive Assessment 13 4.1 Overview 13 4.2 Strategic Competitor Assessment 13 4.3 Product Profile for the Major Marketed Products in the Major Depressive Disorder Market 14 4.3.1 Lexapro/Cipralex (Escitalopram oxalate) 14 4.3.2 Cymbalta (Duloxetine Hydrochloride) 4.3.3 Abilify (Aripiprazole) 4.3.4 Pristiq (Desvenlafaxine succinate) 17 4.3.5 Symbyax (Olanzapine and fluoxetine Hcl) 18 4.4 Key Takeaway 20 5 Major Depressive Disorder Market: Pipeline Assessment 21 5.1 Overview 21 5.2 Strategic Pipeline Assessment 21 5.2.1 Technology Trends Analytic Framework 21 5.3 Major Depressive Disorder Therapeutics - Promising Drugs under Clinical Development 23 5.4 Molecule Profile for Promising Drugs under Clinical Development 24 5.4.1 Vilazodone 24 5.4.2 TC 5214 25 5.4.3 LU AA21004 25 5.5 Major Depressive Disorder Therapeutics Market - Clinical Pipeline by Mechanism of Action 26 5.6 Major Depressive Disorder - Pipeline by Clinical Phases of Development 27 5.6.1 Major Depressive Disorder Therapeutics - Phase III Clinical Pipeline 28 5.6.2 Major Depressive Disorder Therapeutics - Phase II Clinical Pipeline 29 5.6.3 Major Depressive Disorder Therapeutics - Phase I Clinical Pipeline 31 5.7 Key Takeaway 31 6 Major Depressive Disorder Market: Implications for Future Market Competition 32 7 Major Depressive Disorder Market: Future Players in the MDD Market 33 7.1 Introduction 33 7.2 GlaxoSmithKline plc. 33 7.2.1 Overview 33 7.2.2 CNS Portfolio 34 7.2.3 Major Depressive Disorder Product Portfolio 35 7.3 AstraZeneca 35 7.3.1 Overview 35 7.3.2 CNS Portfolio 36 7.3.3 Major Depressive Disorder Product Portfolio 37 7.3.4 AZD2327 37 Full Table of Contents is available at: -- http://www.fastmr.com/ About GlobalData GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number